Assignee
PHARMACYCLICS LLC
US·65 granted patents·102 pending applications·749 citations·filing 2012–2025
Top patents by PatentIndex Score
167 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0399US9409911B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2013·Granted Aug 9, 2016·42 cites·18 claims
- 0499US9266893B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Feb 23, 2016·40 cites·7 claims
- 0598US10751342B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·5 cites·13 claims
- 0698US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0798US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0898US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0997US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 1097US10653696B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2019·Granted May 19, 2020·5 cites·9 claims
- 1197US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 1297US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 1397US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1496US10478439B2Use of inhibitors of bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2018·Granted Nov 19, 2019·8 cites·17 claims
- 1596US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 1696US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 1796US10016435B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jul 10, 2018·12 cites·8 claims
- 1896US10004746B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jun 26, 2018·9 cites·30 claims
- 1996US9814721B2Use of inhibitors of bruton'S tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2016·Granted Nov 14, 2017·14 cites·11 claims
- 2096US9801883B2Use of inhibitors of bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Oct 31, 2017·11 cites·31 claims
- 2195US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 2295US10010507B1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Jul 3, 2018·23 cites·28 claims
- 2395US9801881B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2013·Granted Oct 31, 2017·13 cites·18 claims
- 2495US9655857B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted May 23, 2017·32 cites·37 claims
- 2595US9556182B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 31, 2017·11 cites·22 claims
- 2694US11672803B2Use of inhibitors of Brutons tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Jun 13, 2023·2 cites·24 claims
- 2794US10828259B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Nov 10, 2020·5 cites·25 claims
- 2894US10695350B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2019·Granted Jun 30, 2020·6 cites·8 claims
- 2994US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 3094US10213386B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Feb 26, 2019·18 cites·23 claims
- 3194US10004745B2Use of inhibitors of Bruton'S tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Jun 26, 2018·7 cites·7 claims
- 3294US9540385B2Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2015·Granted Jan 10, 2017·18 cites·26 claims
- 3394US9415050B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2014·Granted Aug 16, 2016·17 cites·21 claims
- 3493US9795604B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2014·Granted Oct 24, 2017·19 cites·55 claims
- 3593US2024358707A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 3692US9545407B2Formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2015·Granted Jan 17, 2017·51 cites·6 claims
- 3791US10463668B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Granted Nov 5, 2019·8 cites·4 claims
- 3891US9795605B2Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumorsPHARMACYCLICS LLC·Filed 2015·Granted Oct 24, 2017·6 cites·22 claims
- 3991US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 4091US9421208B2Methods for the treatment of solid tumorsPHARMACYCLICS LLC·Filed 2014·Granted Aug 23, 2016·7 cites·15 claims
- 4190US9730938B2Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2015·Granted Aug 15, 2017·16 cites·23 claims
- 4289US10105552B2Formulations of histone deacetylase inhibitor and uses thereofPHARMACYCLICS LLC·Filed 2016·Granted Oct 23, 2018·2 cites·15 claims
- 4389US9533991B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 4489US2023293532A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 4589US2023248730A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 4688US9403032B2Formulations of histone deacetylase inhibitor and uses therofPHARMACYCLICS LLC·Filed 2013·Granted Aug 2, 2016·3 cites·17 claims
- 4788US2025197404A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 4888US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 4988US2025345335A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 5087US2025127781A1Use of inhibitors of bruton's tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
Showing the top 50 of 167 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PHARMACYCLICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →